Xeris Biopharma (XERS) News Today → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free XERS Stock Alerts $1.74 -0.02 (-1.14%) (As of 04/19/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineXeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutionsfinance.yahoo.com - April 5 at 12:23 PMXeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)finance.yahoo.com - April 3 at 6:23 PMXeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conferencefinance.yahoo.com - April 2 at 8:50 AMXeris Biopharma (NASDAQ:XERS) Now Covered by Oppenheimermarketbeat.com - March 28 at 8:29 AMXeris Biopharma Surpasses 2023 Expectations with Strategic Moves Poised for 2024 Growthproactiveinvestors.com - March 18 at 9:49 PMHere's What Analysts Are Forecasting For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) After Its Annual Resultsfinance.yahoo.com - March 9 at 1:59 PMXeris Biopharma (XERS) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 8 at 7:43 PMBrokers Offer Predictions for Xeris Biopharma Holdings, Inc.'s Q2 2024 Earnings (NASDAQ:XERS)marketbeat.com - March 8 at 6:35 AMXeris Biopharma Holdings Inc (XERS) Reports Robust Revenue Growth in Q4 and Full Year 2023finance.yahoo.com - March 7 at 2:41 PMXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcriptinsidermonkey.com - March 7 at 1:01 PMHC Wainwright Boosts Xeris Biopharma (NASDAQ:XERS) Price Target to $6.00marketbeat.com - March 7 at 8:20 AMQ4 2023 Xeris Biopharma Holdings Inc Earnings Callfinance.yahoo.com - March 7 at 12:19 AMXeris Biopharma Shares Drop After Weak 4Q Resultsmarketwatch.com - March 6 at 7:18 PMXeris Pharmaceuticals GAAP EPS of -$0.10 in-line, revenue of $44.39M beats by $0.84Mmsn.com - March 6 at 7:18 PMXERS Stock Earnings: Xeris Biopharma Holdings Meets EPS, Beats Revenue for Q4 2023investorplace.com - March 6 at 2:00 PMXeris Biopharma secures $200M in capital in debt refinancing deal; sees big 4Q revenue jumpproactiveinvestors.com - March 6 at 9:57 AMXeris Biopharma (NASDAQ:XERS) Issues Earnings Results, Misses Estimates By $0.01 EPSmarketbeat.com - March 6 at 7:49 AMXeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Eventsbusinesswire.com - March 6 at 7:02 AMXeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capitalbusinesswire.com - March 6 at 7:00 AMXeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024businesswire.com - February 28 at 7:00 AM3 Breakout Stocks Under $5 to Buy for More Upsidetheglobeandmail.com - February 23 at 7:13 PMXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Short Interest Down 9.7% in Januarymarketbeat.com - February 15 at 1:58 AMFY2023 Earnings Forecast for Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Issued By Leerink Partnrsmarketbeat.com - February 8 at 6:43 AMResearch Analysts Issue Forecasts for Xeris Biopharma Holdings, Inc.'s Q1 2024 Earnings (NASDAQ:XERS)marketbeat.com - February 7 at 8:05 AMXeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conferencefinance.yahoo.com - February 5 at 9:27 AMBig Game or Small, Here's How to Go About Stalking a Traderealmoney.thestreet.com - February 3 at 6:45 PMXeris Biopharma Reaches License Agreement With Amgen On Thyroid Eye Disease Treatmentmarketwatch.com - January 10 at 11:14 AMXeris Biopharma Shares Climb 12% on Amgen License Agreementmarketwatch.com - January 10 at 11:14 AMWhy Is Xeris Biopharma (XERS) Stock Up 12% Today?msn.com - January 10 at 11:14 AMTraders Buy Large Volume of Call Options on Xeris Biopharma (NASDAQ:XERS)marketbeat.com - January 10 at 10:35 AMXeris Biopharma: Speculative Buy, Size Your Position Accordinglyseekingalpha.com - January 9 at 7:27 AMXeris Biopharma Holdings Shares Jump 14% on Raised 2023 Outlookmarketwatch.com - January 4 at 2:58 PMXeris Biopharma sees FY revenue at higher end of guidancemsn.com - January 4 at 9:58 AMXeris Biopharma Updates Its Outlook for 2023finance.yahoo.com - January 4 at 9:58 AMXeris Biopharma Holdings Stock Is A Hold With Robust Performance Into 2024seekingalpha.com - January 1 at 5:43 AMXeris Biopharma Holdings Stock Is A Hold With Robust Performance Into 2024seekingalpha.com - January 1 at 5:43 AMXeris Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - December 27 at 7:47 AMXeris Biopharma Holdings, Inc. (0A8E.L)sg.finance.yahoo.com - December 27 at 12:35 AMMy Top Small-Cap Stock Pick for 2024 Is a Biotech With a Big Opportunityfinance.yahoo.com - December 20 at 5:47 PMXeris Pharmaceuticals, Inc. (XERS)uk.finance.yahoo.com - December 3 at 2:38 PMPresident & COO of Xeris Biopharma Holdings Picks Up 7.5% More Stockfinance.yahoo.com - November 20 at 8:50 AMXeris Biopharma CEO unveils game-changing drug innovations and record financial successfinance.yahoo.com - November 17 at 2:18 PMAnalysts Are Bullish on Top Healthcare Stocks: Avidity Biosciences (RNA), Xeris Pharmaceuticals (XERS)markets.businessinsider.com - November 14 at 11:53 PMXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 10 at 5:27 PMXeris Biopharma Holdings Incmorningstar.com - November 10 at 12:26 PMQ3 2023 Xeris Biopharma Holdings Inc Earnings Callfinance.yahoo.com - November 10 at 2:25 AMXeris expects to hit the high end of revenue guidance after strong 3Q resultsproactiveinvestors.com - November 9 at 4:25 PMI've Prescribed Myself This Biotech Stock to Get Through the Market Messfinance.yahoo.com - November 9 at 4:25 PMXeris Biopharma Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 9 at 9:41 AMXeris Biopharma Holdings Inc (XERS) Reports Substantial Revenue Growth in Q3 2023finance.yahoo.com - November 9 at 9:41 AM Get Xeris Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for XERS and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here Click here for the full story XERS Media Mentions By Week XERS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XERS News Sentiment▼0.000.52▲Average Medical News Sentiment XERS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XERS Articles This Week▼01▲XERS Articles Average Week Get Xeris Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for XERS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NBTX News XBIT News PBYI News TSVT News ACIU News PROC News PRLD News RAPT News XOMA News AEON News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XERS) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy SykesTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xeris Biopharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.